智通財(cái)經(jīng)APP獲悉,香港聯(lián)交所最新資料顯示,6月21日,CEO楊建新增持基石藥業(yè)(02616)16.05萬股,平均每股作價(jià)為1.0912港元,總金額約17.52萬港元。增持后最新持股數(shù)目約為6893.73萬股,持股比例為5.37%。
補(bǔ)充資料:Box 28: Such shares represent the restricted shares units and share options granted and to be issued to Dr. Yang pursuant to the Pre-IPO RSU Scheme, Pre-IPO Share Option Scheme and Post-IPO Incentive Schemes.Total of 3,237, 580 restricted shares units granted to Dr. Yang on January 16, 2019 were all vested by February 16, 2023.